The genetics of PPARG and the skeleton

PPAR Research

Volumn , Issue , 2006, Pages

  Ackert Bicknell, Cheryl ^a   Rosen, Clifford ^a,b  

^a JACKSON LABORATORY   (United States)

^b St Joseph's Hospital Bangor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37649027743     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/PPAR/2006/93258     Document Type: Article

References (64)

1. 1994 WHO assessment of fracture risk and its application toscreening for postmenopausal osteoporosis. WHO technical reportsseries 834
2. S CE Schuit M van der Klift A EAM Weel Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34 1 2004 195 202
3. Q-Y Huang R R Recker H-W Deng deng@creighton.edu Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporosis International 14 9 2003 701 715
4. J Zmuda Y Sheu S Moffett The search for human osteoposis genes. Journal of Musculoskeletal & Neuronal Interactions 6 2006 1 3 15
5. A Schwartz Diabetes mellitus: does it affect bone? Calcified Tissue International 73 2003 6 515 519
6. P A Marcovitz pmarcovitz@beaumont.com H H Tran B A Franklin Usefulness of bone mineral density to predict significant coronary artery disease. The American Journal of Cardiology 96 8 2005 1059 1063
7. H S Glauber W M Vollmer M C Nevitt K E Ensrud E S Orwoll Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. Journal of Clinical Endocrinology & Metabolism 80 4 1995 1118 1123
8. P Meunier J Aaron C Edouard G Vignon Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clinical Orthopaedics and Related Research 80 1971 147 154
9. J Justesen K Stenderup E N Ebbesen L Mosekilde T Steiniche M Kassem Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2 3 2001 165 171
10. S Verma J H Rajaratnam J Denton J A Hoyland R J Byers Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. Journal of Clinical Pathology 55 9 2002 693 698
11. S C Manolagas Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews 21 2 2000 115 137
12. P Ducy R Zhang V Geoffroy A L Ridall G Karsenty Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 5 1997 747 754
13. P Tontonoz E Hu B M Spiegelman Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79 7 1994 1147 1156
14. B Lecka-Czernik bxczernik@life.uams.edu I Gubrij E J Moerman Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2. Journal of Cellular Biochemistry 74 3 1999 357 371
15. J M Gimble C E Robinson X Wu Peroxisome proliferator-activated receptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Molecular Pharmacology 50 1996 5 1087 1094
16. E J Moerman K Teng D A Lipschitz B Lecka-Czernik leckaczernikbeata@uams. edu Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-γ2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell 3 6 2004 379 389
17. B M Spiegelman PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47 1998 4 507 514
18. L Fajas D Auboeuf E Raspe The organization, promoter analysis, and expression of the human PPARγ gene. Journal of Biological Chemistry 272 30 1997 18779 18789
19. L Fajas J-C Fruchart J Auwerx PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter. FEBS Letters 438 1998 1-2 55 60
20. H Sundvold S Lien Identification of a novel peroxisome proliferator-activated receptor (PPAR) γ promoter in man and transactivation by the nuclear receptor RORα1. Biochemical and Biophysical Research Communications 287 2 2001 383 390
21. P Tontonoz E Hu R A Graves A I Budavari B M Spiegelman mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes & Development 8 1994 10 1224 1234
22. K Al-Shali H Cao N Knoers A R Hermus C J Tack R A Hegele robert.hegele@rri.on.ca A single-base mutation in the peroxisome proliferator-activated receptor γ4 promoter associated with altered in vitro expression and partial lipodystrophy. Journal of Clinical Endocrinology and Metabolism 89 11 2004 5655 5660
23. H-W Deng F-H Xu Q-Y Huang A whole-genome linkage scan suggests several genomic regions potentially containing quantitative trait loci for osteoporosis. Journal of Clinical Endocrinology and Metabolism 87 11 2002 5151 5159
24. Y H Lee Y H Rho S J Choi J D Ji G G Song Meta-analysis of genome-wide linkage studies for bone mineral density. Journal of Human Genetics 51 2006 5 480 486
25. C Knouff J Auwerx auwerx@igbmc.u-strasbg.fr Peroxisome proliferator-activated receptor-γ calls for activation in moderation: lessons from genetics and pharmacology. Endocrine Reviews 25 6 2004 899 918
26. S Ogawa T Urano T Hosoi Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor γ gene: PPARγ expression in osteoblasts. Biochemical and Biophysical Research Communications 260 1 1999 122 126
27. E-J Rhee K-W Oh W-Y Lee drlwy@hanmail.net The effects of C 161→ T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-γ gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. American Journal of Obstetrics and Gynecology 192 4 2005 1087 1093
28. Y Hsu Y Zhang X Xu Genetic variation in Alox15, Bmp2, Pparg γ and Igf1 gene is associated with BMD. Journal of Bone and Mineral Research 19 2004 S386
29. D P Kiel S Ferrari L A Cupples Polymorphisms in the PPARγ gene influence bone density in humans. Journal of Bone and Mineral Research 20 2005 S234
30. A Meirhaeghe L Fajas N Helbecque A genetic polymorphism of the peroxisome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans. Human Molecular Genetics 7 1998 3 435 440
31. E J Rhee K W Oh W Y Lee drlwy@hanmail.net Effects of two common polymorphisms of peroxisome proliferator-activated receptor-γ gene on metabolic syndrome. Archives of Medical Research 37 1 2006 86 94
32. V Tavares R D Hirata A C Rodrigues Effect of the peroxisome proliferator-activated receptor-γ C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus. Journal of Endocrinological Investigation 28 2005 2 129 136
33. P C Ng S Henikoff Accounting for human polymorphisms predicted to affect protein function. Genome Research 12 3 2002 436 446
34. V Ramensky P Bork S Sunyaev Human non-synonymous SNPs: server and survey. Nucleic Acids Research 30 17 2002 3894 3900
35. J M Zmuda F Modugno J L Weissfeld Peroxisome proliferator-activated receptor-γ polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction. Oncology 70 2006 3 185 189
36. T Ostergard J Ek Y Hamid Influence of the PPAR-γ2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects. Hormone and Metabolic Research 37 2005 2 99 105
37. F Mousavinasab fmousavi@student.oulu.fi T Tahtinen J Jokelainen Effect of the Pro12Ala polymorphism of the PPARγ2 gene on serum adiponectin changes. Endocrine 27 3 2005 307 309
38. Y Barak M C Nelson E S Ong PPARγ is required for placental, cardiac, and adipose tissue development. Molecular Cell 4 1999 4 585 595
39. T Akune S Ohba S Kamekura PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. The Journal of Clinical Investigation 113 2004 6 846 855
40. J Rieusset J Seydoux S I Anghel Altered growth in male peroxisome proliferator-activated receptor γ (PPARγ) heterozygous mice: involvement of PPARγ in a negative feedback regulation of growth hormone action. Molecular Endocrinology 18 10 2004 2363 2377
41. M Matsushita T Tsuboyama R Kasai Age-related changes in bone mass in the senescence-accelerated mouse (SAM): SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. American Journal of Pathology 125 2 1986 276 283
42. R L Jilka R S Weinstein K Takahashi A M Parfitt S C Manolagas Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. Journal of Clinical Investigation 97 7 1996 1732 1740
43. M J Silva M D Brodt S L Ettner Long bones from the senescence accelerated mouse SAMP6 have increased size but reduced whole-bone strength and resistance to fracture. Journal of Bone and Mineral Research 17 9 2002 1597 1603
44. O Kajkenova B Lecka-Czernik I Gubrij Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. Journal of Bone and Mineral Research 12 11 1997 1772 1779
45. R F Klein R J Turner L D Skinner Mapping quantitative trait loci that influence femoral cross-sectional area in mice. Journal of Bone and Mineral Research 17 10 2002 1752 1760
46. T A Drake E Schadt K Hannani Genetic loci determining bone density in mice with diet-induced atherosclerosis. Physiological Genomics 5 4 2001 205 215
47. W G Beamer K L Shultz L R Donahue Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. Journal of Bone and Mineral Research 16 7 2001 1195 1206
48. M L Bouxsein C Rosen C H Turner Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo. Journal of Bone and Mineral Research 17 4 2002 570 579
49. C Rosen C Ackert-Bicknell M L Adamo Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 35 5 2004 1046 1058
50. C Ackert-Bicknell C Marin-Bivens J Denegre Metabolic and skeletal consequences of a high fat/diabetogenic diet on bone acquisition in a congenic mouse strain with altered osteoblast differentiation. Journal of Bone and Mineral Research 20 2005 S10
51. R F Klein kleinro@ohsu.edu J Allard Z Avnur Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303 5655 2004 229 232
52. S Ichikawa D L Koller M L Johnson Human ALOX12, but not ALOX15, is associated with BMD in white men and women. Journal of Bone and Mineral Research 21 4 2006 556 564
53. N Kubota Y Terauchi H Miki PPAR γ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Molecular Cell 4 1999 4 597 609
54. B Lecka-Czernik E J Moerman D F Grant J M Lehmann S C Manolagas R L Jilka Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143 6 2002 2376 2384
55. S S Deeb L Fajas M Nemoto A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics 20 1998 3 284 287
56. M Stumvoll H Haring The peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism. Diabetes 51 2002 8 2341 2347
57. I Barroso M Gurnell V EF Crowley Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 1999 880 883
58. D Evans J De Heer C Hagemann Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor γ (PPARγ) gene and type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes 109 3 2001 151 154
59. S Moffett E Feingold M Barmada The C 161→ T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated receptorγ Metabolism 54 2005 11 1552 1556
60. K M Thrailkill thrailkillkathrynm@uams.edu C K Jr Lumpkin R C Bunn S F Kemp J L Fowlkes Is insulin an anabolic agent in bone? dissecting the diabetic bone for clues. American Journal of Physiology - Endocrinology and Metabolism 289 5 2005 E735 E745
61. S Botolin M-C Faugere H Malluche M Orth R Meyer L R McCabe mccabel@msu.edu Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice. Endocrinology 146 8 2005 3622 3631
62. P Ducy M Amling S Takeda Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 2000 2 197 207
63. S Takeda F Elefteriou R Levasseur Leptin regulates bone formation via the sympathetic nervous system. Cell 111 2002 3 305 317
64. T Yamauchi J Kamon H Waki The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. Journal of Biological Chemistry 276 44 2001 41245 41254z